CQ Pharmaceutical proposes dividend for first three quarters of 2025

CQ Pharmaceutical Holding has announced its preliminary profit distribution plan for the first three quarters of 2025, proposing a cash dividend of 0.30 yuan per 10 shares (including tax). This proposal, approved by the Ninth Board of Directors at its Twentieth Meeting on December 4, 2025, will be presented for approval at the Fifth Interim Shareholders' Meeting in 2025.

The distribution will be based on 1,712,778,096 shares eligible for profit distribution as of September 30, 2025, after deducting 15,406,600 shares held in the company's buyback special account from the total share capital of 1,728,184,696 shares. The total cash dividend payout is projected to be 51,383,342.88 yuan (including tax). The company clarified that should the total number of shares eligible for profit distribution change before the record date, the total distribution amount will be adjusted proportionally to maintain a consistent per-share dividend.

The board confirmed that the proposed dividend aligns with the company's profitability, operational development, and shareholder return policies, posing no material impact on its operating cash flow or ongoing business. This plan does not involve bonus shares or a conversion of capital reserves into share capital.